EUVIMEDEUVIMED entdecken
Open Access

Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography

Kelvin Supriami, Sarah M Urbut, José R Tello-Ayala, Ozan Unlu, Samuel F Friedman, Roukoz Abou-Karam, Satoshi Koyama, Md Mesbah Uddin, Eugene Pomerantsev, Michael T Lu, Michael C Honigberg, Krishna G Aragam und 5 weitere

JAMA Network Open · 21.01.2025 · 8 (1) · e2455368

DOI: 10.1001/jamanetworkopen.2024.55368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 21.01.2025. Verfasst von Kelvin Supriami und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Coronary Artery Disease, Coronary Angiography. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Disease characteristics of genetically mediated coronary artery disease (CAD) on coronary angiography and the association of genomic risk with outcomes after coronary angiography are not well understood.

Objective

To assess the angiographic characteristics and risk of post–coronary angiography outcomes of patients with genomic drivers of CAD: familial hypercholesterolemia (FH), high polygenic risk score (PRS), and clonal hematopoiesis of indeterminate potential (CHIP). Design, Setting, and Participants A retrospective cohort study of 3518 Mass General Brigham Biobank participants with genomic information who underwent coronary angiography was conducted between July 18, 2000, and August 1, 2023. Exposures The presence of a genomic risk factor of CAD, defined as FH variant, high CAD PRS, or CHIP driver variation. Main Outcomes and Measures Coronary artery disease presentation (stable or acute), angiographic CAD characteristics (severity and burden), angiographic outcomes (repeat angiogram, revascularization, and in-stent restenosis), and clinical outcomes (heart failure and all-cause mortality).

Results

Among 3518 participants (2467 [70.1%] male; median age, 64.0 [IQR, 55.0-72.0] years), 1509 (42.9%) had at least 1 genomic driver of CAD (26 FH, 1191 high CAD PRS, and 466 CHIP) that was associated with the presentation of acute coronary syndromes (adjusted odds ratio, 2.67; 95% CI, 2.19-3.26) and with the presence, burden, and severity of angiographic CAD. This association was driven by FH and CAD PRS. One SD of CAD PRS was associated with a 12.51-point higher Gensini score. During 9 years of follow-up, there was an increased risk among FH carriers for a repeat angiogram (adjusted hazard ratio [AHR], 1.70; 95% CI, 1.02-2.83), and revascularization (AHR, 1.97; 95% CI, 1.02-3.80), and among people with high CAD PRS (repeat angiogram: AHR, 1.79; 95% CI, 1.45-2.22; revascularization: AHR, 1.85; 95% CI, 1.37-2.50; and in-stent restenosis: AHR, 3.89; 95% CI, 2.16-7.01). CHIP carriers had no significant increase in angiographic outcomes but were at higher risk of heart failure (AHR, 1.58; 95% CI, 1.04-2.40) and all-cause mortality (AHR, 1.78; 95% CI, 1.47-2.16). Conclusions and Relevance The findings of this study suggest that germline monogenic and polygenic risk are associated with acute coronary syndromes presentation, severity and burden of atherosclerosis, and risk of repeat angiogram, revascularization, and in-stent restenosis. CHIP variant status is associated with incident heart failure and mortality after coronary angiography.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseCoronary AngiographyHumansMaleFemaleMiddle AgedAgedRetrospective StudiesRisk FactorsHyperlipoproteinemia Type IIGenomics

Autor:innen und Institutionen

  • Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Division of Cardiology, Massachusetts General Hospital, Boston.
  • John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts.
  • Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.

Förderung

  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Supriami, K., Urbut, S. M., Tello-Ayala, J. R., Unlu, O., Friedman, S. F., Abou-Karam, R., Koyama, S., Uddin, M. M., Pomerantsev, E., Lu, M. T., Honigberg, M. C., Aragam, K. G., Doshi-Velez, F., Patel, A. P., Natarajan, P., Ellinor, P. T., & Fahed, A. C. (2025). Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography. JAMA Network Open, 8(1), e2455368. https://doi.org/10.1001/jamanetworkopen.2024.55368

Vancouver

Supriami K, Urbut SM, Tello-Ayala JR, Unlu O, Friedman SF, Abou-Karam R, et al. Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography. JAMA Network Open. 2025;8(1):e2455368. doi:10.1001/jamanetworkopen.2024.55368

BibTeX
@article{Supriami2025,
  author = {Supriami, Kelvin and Urbut, Sarah M and Tello-Ayala, José R and Unlu, Ozan and Friedman, Samuel F and Abou-Karam, Roukoz and Koyama, Satoshi and Uddin, Md Mesbah and Pomerantsev, Eugene and Lu, Michael T and Honigberg, Michael C and Aragam, Krishna G and Doshi-Velez, Finale and Patel, Aniruddh P and Natarajan, Pradeep and Ellinor, Patrick T and Fahed, Akl C},
  title = {Genomic Drivers of Coronary Artery Disease and Risk of Future Outcomes After Coronary Angiography},
  journal = {JAMA Network Open},
  year = {2025},
  volume = {8},
  number = {1},
  pages = {e2455368},
  doi = {10.1001/jamanetworkopen.2024.55368}
}
Kostenlos starten →